Stay updated on Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study history shows a new Revision: v3.6.5, replacing the prior v3.6.4. This indicates an update to the record's metadata rather than any change to the trial data.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry v3.6.4 was added to the study record history, and the previous revision v3.6.3 was removed from the visible history.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry v3.6.3 was added to the study history, updating the revision history to reflect the latest version.SummaryDifference0.1%

- Check59 days agoChange DetectedA new revision entry v3.6.2 was added and the previous revision v3.6.0 was removed from the history, updating the page's revision list to reflect the latest state.SummaryDifference0.1%

- Check66 days agoChange DetectedNo textual changes are recorded in the study history for this record. The history indicates the content remained unchanged across reviewed versions.SummaryDifference0.1%

- Check73 days agoChange DetectedThe study history now indicates recruitment is closed with 'No longer looking for participants,' and the log includes a new 'Revision: v3.6.0' entry alongside the deletion of 'Revision: v3.5.5.'SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.